Wuhan Heyuan Biotech's Plant-derived Recombinant Human Serum Albumin Industrialization Base Construction Project, Phase I

Wuhan Heyuan Biotech's Plant-derived Recombinant Human Serum Albumin Industrialization Base Construction Project, Phase I

As a leading company in my country's plant-derived recombinant human serum albumin (HSA), Wuhan Heyuan Biopharmaceuticals shoulders the crucial mission of breaking the monopoly of foreign technology. The project involves core processes such as large-scale biofermentation, precision purification, and aseptic production, placing extremely high demands on the stability and purity of the power system. Any voltage fluctuations or harmonic interference could affect the biological reaction process, potentially leading to production interruptions and product loss.

In response to the project's strict requirements, the Lafaelt team conducted multiple rounds of on-site investigations and technical calculations, and custom-designed 16 sets of 400Kvar SVG cabinets, 4 sets of 250Kvar SVG cabinets, and 4 sets of 200Kvar SVG cabinets. At the same time, they also provided 8 sets of 450A AHF cabinets, 2 sets of 300A AHF cabinets, and 2 sets of 225A AHF cabinets, thus establishing a dual protection network covering the entire base for power factor correction and harmonic suppression.

From leading enterprises to major national biopharmaceutical projects, lafaelt has consistently demonstrated its brand strength in the power quality field with customized solutions, highly reliable products, and full lifecycle services.